| RS113717721 |
MCIDAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Inborn genetic diseases |
| RS113718290 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfanoid habitus and intellectual disability, Intellectual disability |
| RS113721547 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS113721676 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS113722038 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113726158 |
DSP
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS11373 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS113731555 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS113732809 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Fraser syndrome 1 |
| RS113736090 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, GLDC-related disorder |
| RS113739104 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS113742238 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS113742728 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Complement component 3 deficiency |
| RS113745536 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, LAMB3-related disorder |
| RS113746582 |
MEAK7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113747896 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 8, TMPRSS3-related disorder |
| RS113752862 |
RPL35A
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia 5 |
| RS113755498 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS113756713 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS113758103 |
TAT
|
Health Risk |
Likely pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS113759732 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS113760892 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
OBSCN-related disorder, OBSCN-related disorder |
| RS113760990 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1137617 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Ovarian serous cystadenocarcinoma |
| RS113767658 |
ARG1
|
Health Risk |
Pathogenic |
Arginase deficiency, Arginase deficiency |
| RS113768282 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS113768654 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital factor V deficiency, Inborn genetic diseases |
| RS113772629 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113773415 |
FSIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113777932 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS113777945 |
AKT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 6, Cowden syndrome 6 |
| RS113782060 |
MRPL44
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113782618 |
C3
|
Health Risk |
Likely pathogenic |
Complement component 3 deficiency, Complement component 3 deficiency |
| RS113783861 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS113785045 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMC3-related disorder |
| RS113785794 |
CDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113786411 |
COL27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113786548 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 1, Familial thoracic aortic aneurysm and aortic dissection |
| RS113786762 |
TGFBR2
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1137887 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS113794264 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS113794453 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS113802539 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4C, Susceptibility to mononeuropathy of the median nerve |
| RS113803100 |
NTN4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113803159 |
ATP2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brody myopathy, ATP2A1-related disorder |
| RS113803353 |
TMPRSS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcytic anemia, TMPRSS6-related disorder |
| RS113803601 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS113804402 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, LRP5-related disorder |
| RS113808353 |
LRRC56
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113809568 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113811959 |
OPTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary open angle glaucoma, Amyotrophic lateral sclerosis type 12 |
| RS113812219 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS113812345 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113812662 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS113813309 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-1-antitrypsin deficiency, Inborn genetic diseases |
| RS113813525 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113814258 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
von Willebrand disease type 3, von Willebrand disease type 1 |
| RS113817720 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, SERPINA1-related disorder |
| RS113817827 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS113818201 |
PLIN4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113820929 |
MYPN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1KK, Dilated cardiomyopathy 1KK |
| RS113823160 |
GATA5
|
Health Risk |
Conflicting classifications of pathogenicity |
GATA5-related disorder, GATA5-related disorder |
| RS113824905 |
PSAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neu-Laxova syndrome 2, PSAT deficiency |
| RS113826825 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS113828929 |
COL6A2
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1A, Bethlem myopathy 1A |
| RS113829803 |
TNS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid cancer, nonmedullary |
| RS113829901 |
RFT1
|
Health Risk |
Conflicting classifications of pathogenicity |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS113837859 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113840224 |
SUCLG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS113842781 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS113843907 |
COLQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 5, See cases |
| RS113846383 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS113847452 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS113847665 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS113848347 |
MYH8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hecht syndrome, Hecht syndrome |
| RS113849804 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS113852309 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS113856002 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Sotos syndrome |
| RS113857788 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS113860402 |
RRM2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 |
| RS113861754 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS113863223 |
ZMIZ1
|
Health Risk |
Likely pathogenic |
— |
| RS113867661 |
PLK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113870721 |
FCSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation with defective fucosylation 2, Congenital disorder of glycosylation with defective fucosylation 2 |
| RS113871094 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113871730 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS113872601 |
CRYBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 22 multiple types, Inborn genetic diseases |
| RS113874709 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113876817 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
TNNT2-related disorder, Cardiomyopathy |
| RS113877354 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS113878846 |
KIF21A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KIF21A-related disorder |
| RS113879010 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS113879661 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS113882528 |
PI4KA
|
Health Risk |
Conflicting classifications of pathogenicity |
Polymicrogyria, perisylvian |
| RS113886269 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS113887538 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS113891837 |
CTR9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CTR9-related disorder |
| RS113895168 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal macular dystrophy type 2, Retinitis pigmentosa |
| RS113896755 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS113897548 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Hereditary spastic paraplegia 2 |